Showing results (491-500 of 1,892) with videos related to
Sort By:
Pageof 190
Immunotherapy|June 5, 2019
The evolving landscape of immunotherapy in advanced prostate cancerVaibhav G Patel, William K OhImmunotherapy|June 21, 2019
Beta-2 microglobulin knockout K562 cell-based artificial antigen presenting cells for ex vivo expansion of T lymphocytesShijun Zha, Zhendong Li, Can Chen, et al.Immunotherapy|June 26, 2019
Tolerability and surrogate efficacy parameters of a polymerized depot mixture pollen extracts without dilutional effectJoaquín Quiralte, María Angeles Lara, Gemma Vanesa Sánchez, et al.Immunotherapy|April 29, 2015
A Phase I clinical trial with subcutaneous immunotherapy vaccine of Timothy grass pollen extract according to EMA guidelinesJavier Sola, Vanesa Sánchez, Araitz Landeta, et al.Immunotherapy|April 29, 2015
Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern?Fabiola Atzeni, Luigi Gianturco, Rossella Talotta, et al.Immunotherapy|April 29, 2015
New York esophageal squamous cell carcinoma-1 and cancer immunotherapyAli Esfandiary, Soudeh Ghafouri-FardImmunotherapy|August 4, 2016
Cytokine-induced killer cell therapy-associated idiopathic thrombocytopenic purpura: rare but noteworthyXiaomin Fu, Yong Zhang, Quanli Gao, et al.Immunotherapy|August 4, 2016
PD-L1 expression and outcome of advanced melanoma patients treated with anti-PD-1/PD-L1 agents: a meta-analysisOmar Abdel-RahmanImmunotherapy|August 4, 2016
Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapyZulmarie Perez Horta, Jacob L Goldberg, Paul M SondelImmunotherapy|April 7, 2021
Immunotherapy retreatment: case report, review of the literature and proposal for the definition of different scenariosRoberto Borea, Alessandra Damassi, Sara Elena Rebuzzi, et al.Pageof 190